Effect of endopeptidase-24.11 inhibitors and C-ANP receptor ligand on responses evoked in arterioles of rat cremaster muscle by atrial natriuretic peptide
- PMID: 8719785
- PMCID: PMC1909177
- DOI: 10.1111/j.1476-5381.1995.tb15113.x
Effect of endopeptidase-24.11 inhibitors and C-ANP receptor ligand on responses evoked in arterioles of rat cremaster muscle by atrial natriuretic peptide
Abstract
1. The present study examined the effect of exogenous atrial natriuretric peptide (ANP), alone or in presence of inhibitors of the two major mechanisms for clearing ANP, metabolism by neutral endopeptidase-24.11 (NEP) and internalization by C-ANP receptors, on arteriolar responses using intravital microscopy on the rat cremaster muscle after intravenous or topical administration of the peptide. 2. Topical application of ANP (3 x 10(-10) to 3 x 10(-8) M) produced a gradual increase in arteriolar diameter. NEP inhibitors, thiorphan (30 mg kg-1, i.v.), kelatorphan (10 mg kg-1, i.v.) and retrothiorphan (25 mg kg-1, i.v.) alone, did not significantly affect vascular tone but caused significant potentiation of the arteriolar responses to topically applied ANP. 3. When given as an i.v. bolus, ANP dilates skeletal arterioles at a high dose (20 micrograms kg-1). At a lower dose (10 micrograms kg-2), ANP alone or with retrothiorphan or the C-ANP receptor ligand C-ANP (4-23) did not produce any arteriolar responses, while after the combined administration of the two inhibitors, an increase in arteriolar diameter was induced. 4. These results indicate that low doses of topically applied ANP dilate rat cremaster arterioles and that the vasodilator responses can be potentiated by NEP inhibition. When given as an i.v. bolus, a high dose of ANP can also dilate skeletal arterioles. However at a lower dose the rapid metabolism of the peptide prevents it from producing its action.
Similar articles
-
Inhibition of neutral endopeptidase potentiates the effects of atrial natriuretic peptide on acute cyclosporin-induced nephrotoxicity.Nephron. 2000 Nov;86(3):298-305. doi: 10.1159/000045785. Nephron. 2000. PMID: 11096287
-
Neutral endopeptidase inhibition potentiates the effects of natriuretic peptides in renin transgenic rats.Hypertens Res. 1996 Dec;19(4):229-38. doi: 10.1291/hypres.19.229. Hypertens Res. 1996. PMID: 8986453
-
Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.Endocrinology. 1992 Feb;130(2):755-65. doi: 10.1210/endo.130.2.1531129. Endocrinology. 1992. PMID: 1531129
-
Neutral endopeptidase inhibitors and the pulmonary circulation.Gen Pharmacol. 1996 Jun;27(4):581-5. doi: 10.1016/0306-3623(95)02051-9. Gen Pharmacol. 1996. PMID: 8853287 Review.
-
Neutral endopeptidase inhibitors and atrial natriuretic peptide.J Clin Pharmacol. 1991 Aug;31(8):758-62. doi: 10.1002/j.1552-4604.1991.tb03773.x. J Clin Pharmacol. 1991. PMID: 1831818 Review.
Cited by
-
Atrial natriuretic peptide enhances microvascular albumin permeability by the caveolae-mediated transcellular pathway.Cardiovasc Res. 2012 Jan 1;93(1):141-51. doi: 10.1093/cvr/cvr279. Epub 2011 Oct 24. Cardiovasc Res. 2012. PMID: 22025581 Free PMC article.
-
Acute effect of the dual angiotensin-converting enzyme and neutral endopeptidase 24-11 inhibitor mixanpril on insulin sensitivity in obese Zucker rat.Br J Pharmacol. 2001 Jun;133(4):495-502. doi: 10.1038/sj.bjp.0704098. Br J Pharmacol. 2001. PMID: 11399666 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources